Ovarian Cancer News

CancerConnect ovarian cancer news, tips, and features provide breaking research stories, helpful tips, and inspiring features related to ovarian cancer. The unique daily cancer news service evaluates all aspects of ovarian cancer research and reports on the developments that are most important to cancer patients and healthcare providers, while the tips and features offer insight into all aspects of ovarian cancer treatment and survivorship.

Share

Ovarian Cancer News


West Los Angeles’s Premier Cancer Prevention 5K Gets Families Moving (August 28, 2015)

The Kickin’ Cancer!® 5K & Family Fun Day is the Lynne Cohen Foundation’s flagship event to fight women’s cancers, and has been a favorite in West Los Angeles since 2001. As an established community... Continue Reading

Drug Rucaparib Promising in Pretreated BRCA-Positive Ovarian Cancer (June 15, 2015)

The drug rucaparib appears active in women with recurrent BRCA-positive ovarian cancer that has progressed after previous treatment. These findings were presented at 2015 Annual Meeting of the American... Continue Reading

AFCR-funded Scientists Discover New Drug Combination to Overcome Chemotherapy Resistance in Ovarian Cancer (May 27, 2015)

A recent discovery of a new combinational treatment approach may help solve the notorious problem of chemotherapy resistance in ovarian cancer, increasing patient survival for one of the deadliest cancer... Continue Reading

Personalized Screening Test for Ovarian Cancer Potentially Game-Changing, says GlobalData (May 18, 2015)

LONDON, UK (GlobalData), 12 May 2015 – The encouraging recent results of a 14-year study by the UK Collaborative Trial of Ovarian Cancer Screening could herald a radical departure from the approach... Continue Reading

Personalized Immunotherapy Delays Recurrence in Ovarian Cancer (May 11, 2015)

A new immunotherapy known as Vigil™ may help delay the recurrence of advanced ovarian cancer. These findings were presented at the 2015 Annual Meeting on Women’s Cancer, March 28–31, in Chicago,... Continue Reading

Combination of Avastin®, Taxol®, and Carboplatin Improves Survival in Recurrent Platinum-Sensitive Ovarian Cancer (April 29, 2015)

The addition of Avastin® (bevacizumab) to Taxol® (paclitaxel) and carboplatin for the treatment of recurrent platinum-sensitive ovarian cancer appears to improve survival. These findings were presented... Continue Reading

Lynparza Approved in Advanced Ovarian Cancer (December 29, 2014)

CancerConnect News: The U.S. Food and Drug Administration has granted accelerated approval to LynparzaTM (olaparib), a new drug treatment for women with advanced ovarian cancer associated with defective... Continue Reading

Avastin Approved by the FDA for Recurrent Ovarian Cancer (December 2, 2014)

The FDA approval was based on the results of the AURELIA clinical trial, which involved 361 women with ovarian cancer that had recurred less than 6 months after their most recent platinum-based chemotherapy... Continue Reading

AFCR Scientists Uncovered Potential New Treatment for Ovarian Cancer (November 11, 2014)

(CancerConnect) A potential new treatment for ovarian cancer – the most lethal cancer of the female reproductive system – has recently been uncovered, thanks to research supported in part by the... Continue Reading

Adding Cediranib to Olaparib Markedly Improves Progression-Free Survival but Increases Toxicity in Recurrent Platinum-Sensitive Ovarian Cancer (October 21, 2014)

The addition of the antiangiogenic agent cediranib to the PARP inhibitor olaparib in women with recurrent platinum-sensitive ovarian cancer improves time to cancer progression and survival. The results... Continue Reading

More Ovarian Cancer News

Latest Ovarian Cancer News By Stage


Screening and Prevention

Personalized Screening Test for Ovarian Cancer Potentially Game-Changing, says GlobalData (May 18, 2015)

LONDON, UK (GlobalData), 12 May 2015 – The encouraging recent results of a 14-year study by the UK Collaborative Trial of Ovarian Cancer Screening could herald a radical departure from the approach established by other screening tests for cancer,... Continue Reading

Ovarian Cancer Talk: Participate in a Live Video Chat With the Experts from Roswell Park Cancer Institute (September 22, 2014)

Straight from Roswell Park Cancer Institute in Buffalo, N.Y., to your computer or mobile device, four leading experts in ovarian cancer will broadcast a live, interactive video chat from 6 to 7 p.m. on Monday, September 22, 2014. The multidisciplinary... Continue Reading

National Gynecologic Cancer Awareness Month on CancerConnect (September 9, 2014)

Sun Valley, ID & Fort Worth, TX– OMNI Health Media (OMNI) announces the launch of cervical, ovarian and uterine cancer educational programs for national gynecologic cancer awareness month. As the month of September brings gynecologic cancers... Continue Reading

National Ovarian Cancer Awareness Month on CancerConnect (September 2, 2014)

Sun Valley, ID & Fort Worth, TX– OMNI Health Media (OMNI) announces the launch of ovarian cancer educational programs for national ovarian cancer awareness month. As the month of September brings ovarian cancer into focus, it’s time to increase... Continue Reading

Aspirin as Ovarian Cancer Prevention? Research Says Maybe (February 20, 2014)

New evidence suggests that an aspirin a day may reduce the risk of ovarian cancer. But more research is needed before your doctor will routinely prescribe it for prevention. You may know that low doses of aspirin, taken daily, can help reduce the risk... Continue Reading

More Screening and Prevention

Stage I

Ovarian Cancer Talk: Participate in a Live Video Chat With the Experts from Roswell Park Cancer Institute (September 22, 2014)

Straight from Roswell Park Cancer Institute in Buffalo, N.Y., to your computer or mobile device, four leading experts in ovarian cancer will broadcast a live, interactive video chat from 6 to 7 p.m. on Monday, September 22, 2014. The multidisciplinary... Continue Reading

National Gynecologic Cancer Awareness Month on CancerConnect (September 9, 2014)

Sun Valley, ID & Fort Worth, TX– OMNI Health Media (OMNI) announces the launch of cervical, ovarian and uterine cancer educational programs for national gynecologic cancer awareness month. As the month of September brings gynecologic cancers... Continue Reading

National Ovarian Cancer Awareness Month on CancerConnect (September 2, 2014)

Sun Valley, ID & Fort Worth, TX– OMNI Health Media (OMNI) announces the launch of ovarian cancer educational programs for national ovarian cancer awareness month. As the month of September brings ovarian cancer into focus, it’s time to increase... Continue Reading

Aspirin as Ovarian Cancer Prevention? Research Says Maybe (February 20, 2014)

New evidence suggests that an aspirin a day may reduce the risk of ovarian cancer. But more research is needed before your doctor will routinely prescribe it for prevention. You may know that low doses of aspirin, taken daily, can help reduce the risk... Continue Reading

Live Web Chat on “The Latest in Ovarian Cancer Treatment,” featuring Dana-Farber/Brigham and Women’s Cancer Center Expert (September 17, 2013)

On September 17th Dana-Farber/Brigham and Women’s Cancer Center gynecologic oncology expert, Ursula A. Matulonis, MD, presented an overview of the latest in ovarian cancer treatment and answered questions during a live Web chat. Dr. Matulonis is the... Continue Reading

More Stage I

Stages II-IV

Personalized Immunotherapy Delays Recurrence in Ovarian Cancer (May 11, 2015)

A new immunotherapy known as Vigil™ may help delay the recurrence of advanced ovarian cancer. These findings were presented at the 2015 Annual Meeting on Women’s Cancer, March 28–31, in Chicago, Illinois. According to the American Cancer Society... Continue Reading

Combination of Avastin®, Taxol®, and Carboplatin Improves Survival in Recurrent Platinum-Sensitive Ovarian Cancer (April 29, 2015)

The addition of Avastin® (bevacizumab) to Taxol® (paclitaxel) and carboplatin for the treatment of recurrent platinum-sensitive ovarian cancer appears to improve survival. These findings were presented at the 2015 Annual Meeting on Women’s Cancer,... Continue Reading

Lynparza Approved in Advanced Ovarian Cancer (December 29, 2014)

CancerConnect News: The U.S. Food and Drug Administration has granted accelerated approval to LynparzaTM (olaparib), a new drug treatment for women with advanced ovarian cancer associated with defective BRCA genes. According to statistics from the American... Continue Reading

Adding Cediranib to Olaparib Markedly Improves Progression-Free Survival but Increases Toxicity in Recurrent Platinum-Sensitive Ovarian Cancer (October 21, 2014)

The addition of the antiangiogenic agent cediranib to the PARP inhibitor olaparib in women with recurrent platinum-sensitive ovarian cancer improves time to cancer progression and survival. The results of this study were recently reported in The Lancet... Continue Reading

Ovarian Cancer Talk: Participate in a Live Video Chat With the Experts from Roswell Park Cancer Institute (September 22, 2014)

Straight from Roswell Park Cancer Institute in Buffalo, N.Y., to your computer or mobile device, four leading experts in ovarian cancer will broadcast a live, interactive video chat from 6 to 7 p.m. on Monday, September 22, 2014. The multidisciplinary... Continue Reading

More Stages II-IV

Recurrent

Drug Rucaparib Promising in Pretreated BRCA-Positive Ovarian Cancer (June 15, 2015)

The drug rucaparib appears active in women with recurrent BRCA-positive ovarian cancer that has progressed after previous treatment. These findings were presented at 2015 Annual Meeting of the American Society of Clinical Oncology (May 29–June 2, Chicago,... Continue Reading

Combination of Avastin®, Taxol®, and Carboplatin Improves Survival in Recurrent Platinum-Sensitive Ovarian Cancer (April 29, 2015)

The addition of Avastin® (bevacizumab) to Taxol® (paclitaxel) and carboplatin for the treatment of recurrent platinum-sensitive ovarian cancer appears to improve survival. These findings were presented at the 2015 Annual Meeting on Women’s Cancer,... Continue Reading

Lynparza Approved in Advanced Ovarian Cancer (December 29, 2014)

CancerConnect News: The U.S. Food and Drug Administration has granted accelerated approval to LynparzaTM (olaparib), a new drug treatment for women with advanced ovarian cancer associated with defective BRCA genes. According to statistics from the American... Continue Reading

Avastin Approved by the FDA for Recurrent Ovarian Cancer (December 2, 2014)

The FDA approval was based on the results of the AURELIA clinical trial, which involved 361 women with ovarian cancer that had recurred less than 6 months after their most recent platinum-based chemotherapy treatment. The   phase III trial compared... Continue Reading

AFCR Scientists Uncovered Potential New Treatment for Ovarian Cancer (November 11, 2014)

(CancerConnect) A potential new treatment for ovarian cancer – the most lethal cancer of the female reproductive system – has recently been uncovered, thanks to research supported in part by the Asian Fund for Cancer Research (AFCR). AFCR-funded... Continue Reading

More Recurrent

CancerConnect Cancer Commuity & Discussions


Cancer Types

Sign up for the CancerConnect newsletter

Sign up for our newsletter and receive the latest news and updates about specific types of cancer.

  Close |  Please don't show me this again

Facebook Twitter RSS